NON-SMALL CELL 20190436

Study #20190436

A Multicenter, Open-label, Single-arm, Expanded Access Protocol of AMG 510 (Sotorasib) for the Treatment of Subjects with Previously Treated Locally Advanced Unresectable / Metastatic NSCLC with KRAS p.G12C Mutation

Back To Clinical Trials